National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, and Discipline of Paediatrics and Child Health, University of Sydney, Children's Hospital at Westmead, Westmead, Australia;
Telethon Institute for Child Health Research, University of Western Australia, Subiaco, Australia; Menzies School of Health Research, Charles Darwin University, Casuarina, Australia; and.
Pediatrics. 2014 Oct;134(4):713-20. doi: 10.1542/peds.2014-1105. Epub 2014 Sep 15.
Although recommended for almost a decade, evidence for field effectiveness of vaccinating close adult contacts of newborn infants against pertussis ("cocooning") is lacking. We evaluated the impact of a government-funded cocoon program during a pertussis epidemic in New South Wales, Australia.
We matched all New South Wales laboratory-confirmed pertussis cases aged <4 months with onset between April 1, 2009, to March 30, 2011 to controls from the state birth register by date of birth and area of residence. Parental vaccine receipt was by self-report, with a subset verified. Parents were considered "immunized" if vaccinated ≥4 weeks before case symptom onset. The effectiveness of parental immunization (versus neither vaccinated) was quantified as (1 - odds ratio) × 100%.
Case households had fewer immunized mothers (22% vs 32%) or fathers (20% vs 31%) but were more likely to include additional and older children. After adjustment, when both parents met our definition of immunized, risk of pertussis at<4 months of age was reduced by 51% (95% confidence interval 10% to 73%). Maternal vaccination prepregnancy and an immunized father reduced the risk by 51% (95% confidence interval 0% to 76%).
Timely parental pertussis boosters provided significant protection. Evidence of protection from maternal vaccination prepregnancy is biologically plausible, and more precise data on the magnitude and duration of this is important for future policy recommendations.
尽管近十年来一直推荐为新生儿的密切成人接触者接种百日咳疫苗(“围堵”),但缺乏针对该疫苗现场有效性的证据。我们评估了在澳大利亚新南威尔士州百日咳流行期间,一项政府资助的围堵计划的效果。
我们通过出生日期和居住地将新南威尔士州所有实验室确诊的<4 个月大的百日咳病例与 2009 年 4 月 1 日至 2011 年 3 月 30 日发病的对照病例相匹配。父母的疫苗接种情况由自我报告,其中一部分进行了验证。如果父母在病例症状出现前≥4 周接种疫苗,则认为他们“已免疫”。父母免疫(而非两者均未接种)的有效性通过(1 - 比值比)×100%来量化。
病例家庭中免疫的母亲(22% vs. 32%)或父亲(20% vs. 31%)较少,但更有可能包括其他年龄较大的儿童。调整后,当父母双方均符合我们的免疫定义时,<4 个月龄患百日咳的风险降低了 51%(95%置信区间 10%至 73%)。母亲妊娠前接种疫苗和免疫的父亲将风险降低了 51%(95%置信区间 0%至 76%)。
及时为父母接种百日咳加强疫苗可提供显著保护。妊娠前母亲接种疫苗可提供保护的证据具有生物学意义,关于这种保护的程度和持续时间的更准确数据对未来的政策建议很重要。